Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032
| Autor: | Smith, David C., Tangen, Cathy M., Van Veldhuizen, Peter J., Jr., Harrer, Grant W., Golshayan, Ali, Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M., Hussain, Maha H.A. |
|---|---|
| Zdroj: | In Urology 2011 77(5):1172-1176 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect